首页> 外文期刊>Pediatric drugs >A Prospective Cohort Study of Factors Associated with Empiric Antibiotic De-escalation in Neonates Suspected with Early Onset Sepsis (EOS)
【24h】

A Prospective Cohort Study of Factors Associated with Empiric Antibiotic De-escalation in Neonates Suspected with Early Onset Sepsis (EOS)

机译:具有早期发病败血症(EOS)的新生儿患有透学抗生素脱升升级相关因素的预期队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background Prolonged empiric antibiotic use, resulting from diagnostic uncertainties, in suspected early onset sepsis (EOS) cases constitutes a significant problem. Unnecessary antibiotic use increases the risk of antibiotic resistance. Furthermore, prolonged antibiotic use increases the risk of mortality and morbidity in neonates. Proactive measures including empiric antibiotic de-escalation are crucial to overcome these problems. Methods This was a prospective cohort study conducted in the neonatal intensive care units of two public hospitals in Malaysia. Neonates with a gestational age greater than 34 weeks who were started on empiric antibiotics within 72 h of life were screened. The data were then stratified according to de-escalation and non-de-escalation practices, where de-escalation practice was defined as narrowing down or discontinuation of empiric antibiotic within 72 h of treatment. Results A total of 1045 neonates were screened, and 429 were included. The neonates were then divided based on de-escalation (n = 207) and non-de-escalation (n = 222) practices. Neonates under non-de-escalation practices showed significantly longer durations of antibiotic use compared to those under de-escalation practices (p < 0.05), with no difference in treatment outcomes. Five factors were found to be associated with de-escalation of antibiotics. They are cesarean section delivery, exposure to antenatal steroids, nil history of maternal pyrexia, absence of meconium-stained amniotic fluid, and normal C-reactive protein <= 0.5 mg/dL (p < 0.05). Conclusions Empiric antibiotic de-escalation appears feasible as a routine form of treatment for EOS in late preterm and term neonates.
机译:背景技术延长经验抗生素使用,由诊断不确定性导致,在疑似早期发病败血症(EOS)案件中构成了一个重大问题。不必要的抗生素使用增加了抗生素抗性的风险。此外,长期抗生素使用增加了新生儿死亡率和发病率的风险。在克服这些问题的情况下,包括经验抗生素去升级的主动措施是至关重要的。方法这是一项在马来西亚两家公立医院的新生儿重症监护单位进行的预期队列研究。筛选了在生命中72小时内开始于经验抗生素的34周的孕龄的新生儿。然后根据脱升升级和非去升级实践分层数据,其中脱升升级实践定义为在72小时内缩小或停止经验抗生素。结果总共筛选了1045个新生酸盐,包括429个。然后基于去升级(n = 207)和非去升级(n = 222)实践来划分新生儿。与脱升升级实践(P <0.05)下的人相比,NeoNates在非去升级实践下显示出明显更长的抗生素用途(P <0.05),治疗结果没有差异。发现五种因素与脱升抗生素升级有关。它们是剖宫产段递送,暴露于产前类固醇,母体Pyrexia的历史,不存在膀胱染色的羊水,以及正常的C反应蛋白<= 0.5mg / dL(P <0.05)。结论经验抗生素脱升升级作为晚期早产和术语新生儿的EOS的常规形式可行。

著录项

  • 来源
    《Pediatric drugs》 |2020年第3期|共10页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号